| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |